Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 63

Sort by

Sort Order Select

Journal Articles

Predictors of Disease Progression and Survival in Patients with Myelodysplastic Syndrome Secondary to Inherited Bone Marrow Failure Syndromes

Blood (2019) 134 (Supplement_1): 2507.

https://doi.org/10.1182/blood-2019-130129

Published: 2019

Journal Articles

Significance of Abnormalities of PPM1D in Myeloproliferative Neoplasms

Bridget Marcellino, MD PhD, Joseph Tripodi, Michal Bar-Natan, MD, Harry Fruchtman, Noushin Farnoud, PhD, Min Lu, PhD, Heidi E. Kosiorek, MS, Amylou C. Dueck, PhD, Raajit K. Rampal, MD PhD, John Mascarenhas, MD, Vesna Najfeld, PhD, Ronald Hoffman, MD

Blood (2019) 134 (Supplement_1): 4207.

https://doi.org/10.1182/blood-2019-129565

Published: 2019

Journal Articles

An Acquired High-Risk Chromosome Instability Phenotype in Multiple Myeloma: Jumping 1q Syndrome

Jeffery R. Sawyer, Erming Tian, PhD MBA, Brian A Walker, PhD, Christopher P. Wardell, PhD MSc, BSc, Joshua Epstein, DSc, Janet L Lukacs, Gael M. Sammartino, Clyde Bailey, Carolina D. Schinke, MD, Sharmilan Thanendrarajan, MD, Maurizio Zangari, MD, Faith E. Davies, MD, Frits van Rhee, MD PhD, Gareth Morgan, MD

Blood (2018) 132 (Supplement 1): 4489.

https://doi.org/10.1182/blood-2018-99-115090

Published: 2018

Journal Articles

Hematologic Malignancies Arising in Patients with Germ Cell Tumors: Secondary Somatic Differentiation of Hematopoietic Malignancies from Germ Cell Precursors

Justin Taylor, MD, Mark Donoghue, PhD, Raajit K. Rampal, MD PhD, Roni Tamari, MD, Martin S. Tallman, MD, Darren R. Feldman, MD, Barry S Taylor, PhD, Omar I Abdel-Wahab, MD

Blood (2018) 132 (Supplement 1): 87.

https://doi.org/10.1182/blood-2018-99-111976

Published: 2018

Journal Articles

Myeloid/Histiocytic Neoplasms Associated with Germ Cell Tumors Harbor Shared Genetic Abnormalities Indicating a Clonal Relationship, Unique Molecular Pathogenesis and Cellular Origin

Caleb Ho, MD, Yanming Zhang, MD, Umut Aypar, PhD, Mariko Yabe, MD PhD, Filiz Sen, MD, Maria E Arcila, MD, Ahmet Dogan, MD PhD, Kseniya Petrova-Drus, MD PhD

Blood (2018) 132 (Supplement 1): 3077.

https://doi.org/10.1182/blood-2018-99-115698

Published: 2018

Journal Articles

Robust Parsing and Automated ELN Risk Classification for Acute Myeloid Leukemia

Emily Silgard, MS, Min Fang, MDPhD

Blood (2017) 130 (Supplement 1): 3947.

https://doi.org/10.1182/blood.V130.Suppl_1.3947.3947

Published: 2017

Journal Articles

Chromosome 1q12 Instability Drives Both 1q21 Amplification and Arm-Length Deletions in Multiple Myeloma

Jeffery R. Sawyer, Erming Tian, PhD MBA, Brian A Walker, PhD, Charles M. Swanson, Janet L Lukacs, Gael M. Sammartino, Clyde Bailey, Sharmilan Thanendrarajan, MD, Carolina D. Schinke, MD, Maurizio Zangari, MD, Frits van Rhee, MD PhD, Faith E. Davies, MD, Gareth J. Morgan, MD PhD

Blood (2017) 130 (Supplement 1): 3060.

https://doi.org/10.1182/blood.V130.Suppl_1.3060.3060

Published: 2017

Journal Articles

Pattern of Mutational Changes in Patients with Chronic Phase CML Who Are Treated with Frontline TKI and Transform to Blast Phase CML

Preetesh Jain, MBBS,MDDM,PhD, Rashmi Kanagal-Shamanna, MD, Hagop M. Kantarjian, MD, F. Anthony San Lucas, Ahmad Ghorab, MDMSc, Elias J. Jabbour, MD, Issa Ghayas, Koji Sasaki, MD, Tapan Kadia, MD, Zeev Estrov, MD, Farhad Ravandi, MBBS, Jorge E. Cortes, MD

Blood (2017) 130 (Supplement 1): 4172.

https://doi.org/10.1182/blood.V130.Suppl_1.4172.4172

Published: 2017

Journal Articles

Analyzing the Transcriptome Discovers up-Regulation of HOXA Genes in Patients with Myeloid Neoplasms and Isochromosome 17q and Mutations in ASXL1 , SETBP1 and SRSF2

Manja Meggendorfer, PhD, Niroshan Nadarajah, M.Sc., Claudia Haferlach, MD, Wolfgang Kern, MD, Torsten Haferlach, MD

Blood (2016) 128 (22): 2703.

https://doi.org/10.1182/blood.V128.22.2703.2703

Published: 2016

Journal Articles

Germline and Somatic Genetic Characterization of Shwachman-Diamond Syndrome

Kasiani C. Myers, MD, Adam S. Nelson, MBBS, Brian Sheehan, Maggie Malsch, Gwendolyn Towers, Audrey Anna Bolyard, RN, BS, Joan Moore, Sara Loveless, Leann Mount, Stella M Davies, MBBS, PhD, Siobán B. Keel, MD, Rabi Hanna, MD, Mark D. Fleming, MD DPhil, David C. Dale, MD, Akiko Shimamura, MD PhD

Blood (2016) 128 (22): 2681.

https://doi.org/10.1182/blood.V128.22.2681.2681

Published: 2016

Journal Articles

Prognostic Value of Clonal Evolution at the Time of Diagnosis in Patients with Chronic Myeloid Leukemia Treated with Frontline Tyrosine Kinase Inhibitors

Ahmad Alhuraiji, MD MRCP, Hagop M. Kantarjian, MD, Elias J. Jabbour, MD, Prajwal Chaitanya Boddu, MD, Farhad Ravandi, MD, Gautam Borthakur, MD, Courtney D DiNardo, MD, Naval Daver, MD, Tapan M. Kadia, MD, Naveen Pemmaraju, MD, Sherry Pierce, BSN, BA, Guillermo Garcia-Manero, MD, Jorge E. Cortes, MD

Blood (2016) 128 (22): 3064.

https://doi.org/10.1182/blood.V128.22.3064.3064

Published: 2016

Journal Articles

In Chronic Lymphocytic Leukemia the Gain of the Short Arm of Chromosome 2 Is Highly Associated with an Unmutated IGHV status, 11q/ ATM Deletion, SF3B1 Mutation and a Complex Karyotype

Claudia Haferlach, MD, Sabine Jeromin, PhD, Anna Stengel, PhD, Manja Meggendorfer, PhD, Melanie Zenger, Wolfgang Kern, MD, Torsten Haferlach, MD

Blood (2016) 128 (22): 4379.

https://doi.org/10.1182/blood.V128.22.4379.4379

Published: 2016

Journal Articles

Clonal B-Cell Lymphocytosis with Marginal Zone Features and Splenic Marginal Zone Lymphoma Share a Similar Cytogenetic and Mutational Profile

Paul Legendre, MD, Olivier Kosmider, PharmD, PhD, Coralie Derrieux, PharmD, Nicolas Chapuis, PharmD, PhD, Isabelle Radford-Weiss, PharmD, Hélène Guermouche, Barbara Burroni, MD, Julie Bruneau, MD PhD, Bénédicte Deau, MD, Richard Delarue, MD, Olivier Hermine, MD PhD, Didier Bouscary, MD PhD, David Sibon, MD PhD

Blood (2016) 128 (22): 2962.

https://doi.org/10.1182/blood.V128.22.2962.2962

Published: 2016

Journal Articles

AML with RUNX1 Mutations and Loss of RUNX1 Wild-Type - a Distinct Subset?

Claudia Haferlach, MD, Niroshan Nadarajah, M.Sc., Annette Fasan, PhD, Karolína Perglerová, Wolfgang Kern, MD, Susanne Schnittger, PhD, Torsten Haferlach

Blood (2015) 126 (23): 2578.

https://doi.org/10.1182/blood.V126.23.2578.2578

Published: 2015

Journal Articles

ASXL1 Mutations in Myelodysplastic Syndromes with 1% or More Ring Sideroblasts: Prevalence, Clinical Correlates and Prognostic Relevance

Naseema Gangat, MBBS, Terra L. Lasho, PhD, Mrinal M Patnaik, MBBS, Christy Finke, BS, Mark R Litzow, MD, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD

Blood (2015) 126 (23): 2882.

https://doi.org/10.1182/blood.V126.23.2882.2882

Published: 2015

Journal Articles

The Landscape of Myeloid Neoplasms with Isochromosome 17q Discloses a Specific Mutation Profile and Is Characterized By an Accumulation of Prognostically Adverse Molecular Markers

Manja Meggendorfer, PhD, Claudia Haferlach, MD, Wolfgang Kern, MD, Susanne Schnittger, PhD, Torsten Haferlach

Blood (2015) 126 (23): 1656.

https://doi.org/10.1182/blood.V126.23.1656.1656

Published: 2015

Journal Articles

Prevalence and Clinical Impact of Additional Cytogenetic Abnormalities in Patients (Pts) with Myelodysplastic Syndromes (MDS) and Deletion 5q from the MDS-003 and MDS-004 Studies

Aristoteles Giagounidis, MD PhD, Alan F. List, MD, Eva Hellstrom-Lindberg, MD PhD, Ghulam J. Mufti, MD PhD, Brigitte Schlegelberger, MD PhD, John Morrill, Chengqing Wu, PhD, Barry Skikne, MD, Pierre Fenaux, MD PhD, Gudrun Göhring, MD

Blood (2014) 124 (21): 3270.

https://doi.org/10.1182/blood.V124.21.3270.3270

Published: 2014

Journal Articles

The ASXL1 Gene Alterations in Patients with Myeloid Diseases and Chromosomal 20q Deletion

Jana Brezinova, PhD, Iveta Sarova, PhD, Halka Lhotska, Sarka Ransdorfova, PhD, Silvia Izakova, Karla Svobodova, Jana Markova, Zuzana Zemanova, Ass. Prof.,PhD, Jaroslav Cermak, MD PhD As. Prof., Anna T. Jonasova, MD, Kyra Michalova, PhD Prof.

Blood (2014) 124 (21): 5596.

https://doi.org/10.1182/blood.V124.21.5596.5596

Published: 2014

Journal Articles

Second Report of Arab Leukemia Net (ALN) Registry for Chronic Myeloid Leukemia (CML) in the Middle East &North Africa Region (AFME). Epidemiology of CML and Additional Chromosomal Abnormalities (ACAs) in Egypt, Multicenter Results

Mohamed osman Azzazi, MD PhD, Omar Fahmy, MD PhD, Mervat Mattar, MD PhD, Ashraf El Ghandour, MD PhD, Manal El Sorady, MD PhD, Samir Shehata, MD PhD, Yasser. El Nahass, MD PhD, Hani Hegab, MD PhD, Rasha Ibrahim, MD PhD, Rasha Magdy, MD PhD, Hend Ellithy, MSc,PhD, Mohammad Shazly, MSc, Rana Hussein Khaled, MBBCH, MSc,, Mai Sameir, MBBCH, MSc,, Mohab Elshaer, MBBCH, MSc,

Blood (2014) 124 (21): 5539.

https://doi.org/10.1182/blood.V124.21.5539.5539

Published: 2014

Journal Articles

Clinical, Cytogenetic, Immunophenotypic Characteristics and Outcome of Blastic Phase in Chronic Myeloid Leukemia: A Single Institution Experience

Fernando Pérez, Elena Juventina Tuna, Roberta Demichelis, Erick Crespo, Ubaldo Valencia

Blood (2014) 124 (21): 5540.

https://doi.org/10.1182/blood.V124.21.5540.5540

Published: 2014

NARROW

Predictors of Disease Progression and Survival in Patients with Myelodysplastic Syndrome Secondary to Inherited Bone Marrow Failure Syndromes

Significance of Abnormalities of PPM1D in Myeloproliferative Neoplasms

An Acquired High-Risk Chromosome Instability Phenotype in Multiple Myeloma: Jumping 1q Syndrome

Hematologic Malignancies Arising in Patients with Germ Cell Tumors: Secondary Somatic Differentiation of Hematopoietic Malignancies from Germ Cell Precursors

Myeloid/Histiocytic Neoplasms Associated with Germ Cell Tumors Harbor Shared Genetic Abnormalities Indicating a Clonal Relationship, Unique Molecular Pathogenesis and Cellular Origin

Robust Parsing and Automated ELN Risk Classification for Acute Myeloid Leukemia

Chromosome 1q12 Instability Drives Both 1q21 Amplification and Arm-Length Deletions in Multiple Myeloma

Pattern of Mutational Changes in Patients with Chronic Phase CML Who Are Treated with Frontline TKI and Transform to Blast Phase CML

Analyzing the Transcriptome Discovers up-Regulation of HOXA Genes in Patients with Myeloid Neoplasms and Isochromosome 17q and Mutations in ASXL1 , SETBP1 and SRSF2

Germline and Somatic Genetic Characterization of Shwachman-Diamond Syndrome

Prognostic Value of Clonal Evolution at the Time of Diagnosis in Patients with Chronic Myeloid Leukemia Treated with Frontline Tyrosine Kinase Inhibitors

In Chronic Lymphocytic Leukemia the Gain of the Short Arm of Chromosome 2 Is Highly Associated with an Unmutated IGHV status, 11q/ ATM Deletion, SF3B1 Mutation and a Complex Karyotype

Clonal B-Cell Lymphocytosis with Marginal Zone Features and Splenic Marginal Zone Lymphoma Share a Similar Cytogenetic and Mutational Profile

AML with RUNX1 Mutations and Loss of RUNX1 Wild-Type - a Distinct Subset?

ASXL1 Mutations in Myelodysplastic Syndromes with 1% or More Ring Sideroblasts: Prevalence, Clinical Correlates and Prognostic Relevance

The Landscape of Myeloid Neoplasms with Isochromosome 17q Discloses a Specific Mutation Profile and Is Characterized By an Accumulation of Prognostically Adverse Molecular Markers

Prevalence and Clinical Impact of Additional Cytogenetic Abnormalities in Patients (Pts) with Myelodysplastic Syndromes (MDS) and Deletion 5q from the MDS-003 and MDS-004 Studies

The ASXL1 Gene Alterations in Patients with Myeloid Diseases and Chromosomal 20q Deletion

Second Report of Arab Leukemia Net (ALN) Registry for Chronic Myeloid Leukemia (CML) in the Middle East &North Africa Region (AFME). Epidemiology of CML and Additional Chromosomal Abnormalities (ACAs) in Egypt, Multicenter Results

Clinical, Cytogenetic, Immunophenotypic Characteristics and Outcome of Blastic Phase in Chronic Myeloid Leukemia: A Single Institution Experience

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only